AASLD is actively monitoring events related to the COVID-19 pandemic and will provide timely information and resources to support health care providers in hepatology, liver transplantation and gastroenterology as well as their patients and caregivers. This resource page will be updated regularly as more data become available to the AASLD Leadership.

AASLD News

Message from AASLD President

In the March 24, 2020 issue of AASLD News, AASLD President Jorge A. Bezerra, MD, FAASLD shares his monthly column — "We are Stronger than COVID-19."

Read Dr. Bezerra's column.

NEW! A Message from Wiley regarding Journal Print Disruption during COVID-19

Read AASLD's message to our members.

 

For the Clinician

NEW! AASLD's "Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic"

This document provides data on what is known about COVID-19, and how it may impact hepatologists and liver transplant providers and their patients. Our aim is to provide a basic template for the development of clinical recommendations and policies to mitigate the impact of the COVID-19 pandemic on liver patients and health care providers. This document will continue to evolve and be reviewed by the authors and AASLD Governing Board, and be revised and updated as needed in response to the COVID-19 pandemic.

Read AASLD's Clinical Insights. [Released: March 23, 2020]

NEW! Joint Society Message: Use of Personal Protective Equipment in GI Endoscopy

Read the joint societies' statement.

NEW! Joint Society Message: Gastroenterology Professional Society Guidance on Endoscopic Procedures during the COVID-19 Pandemic

Read the joint societies' statement.

Joint GI Society Message: COVID-19 Clinical Insights for Our Community of Gastroenterologists and Gastroenterology Care Providers

Read the joint GI societies' statement.

NEW! Webinar: "COVID-19 and the Liver – Case Studies and Updates"

On Tuesday, April 7 at 5 pm ET, AASLD will host a webinar dedicated to ongoing discoveries and discussions about COVID-19 and how it impacts the care of liver patients. It will:

  • Highlight recent updates AASLD’s "Clinical Insights" paper
  • Provide short synopses on several research articles
  • Layout a detailed case of a liver patient diagnosed with COVID-19 and steps taken in that patient’s care

Attendees can submit questions in advance via this survey. Questions must be received by Monday, April 6, 11:59 am ET. Once the deadline passes, you can submit your questions directly to the speakers during the liver webinar, time permitting.

Webinar: "COVID-19 and the Liver"

AASLD hosted a webinar that highlighted information from AASLD’s recently released "Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic" paper.

NEW! Watch the pre-recorded webinar.

NEW! Download the slide presentation.

AGA issues formal recommendations for PPE during gastrointestinal procedures

Read AGA's recommendations.

 

AASLD's Clinical and Public Policy Positions

NEW! Centers for Medicare and Medicaid Services

On Monday, March 30, 2020, CMS released an interim final rule and blanket waivers to provide additional flexibilities to providers during the COVID-19 emergency. AASLD’s Government Relations Consultant CRD Associates prepared this summary.

Take Action to Protect Our Community during the Pandemic

The 2019 Novel Coronavirus (COVID-19) has put not only GI professionals but also the entire medical community at risk.

In a joint letter to Congress, AASLD, American College of Gastroenterology (ACG), American Gastroenterological Association (AGA), and American Society for Gastrointestinal Endoscopy (ASGE) call on policymakers to protect you, your colleagues and patients from COVID-19 by:

  • Increasing funding for and access to personal protective equipment (PPE)
  • Easing prior authorization and Medicare reporting requirements
  • Providing financial safeguards for health care professionals and practices.

Join us and make your voice heard: Use our online advocacy tool to send an email to your legislators about how COVID-19 is impacting you and what needs to be done to protect you, your colleagues and your patients during this urgent time.

AASLD advocates to CDC to ensure that patients with liver-related illness are included among vulnerable populations in need of testing services

Read AASLD's letter to the CDC.

Joint GI Society Message: COVID-19 Telehealth Information for Gastroenterologists and Gastroenterology Care Providers

Read the joint GI societies' statement.

 

Other Resources

Centers for Disease Control and Prevention (CDC) Resources

NEW! Food & Drug Administration

American Medical Association

SECURE-Cirrhosis

SECURE-Cirrhosis is a secure, online, de-identified registry of patients with cirrhosis or post-liver transplant who have developed COVID-19.

Visit the SECURE-Cirrhosis website.

 

What You Can Do

AASLD seeks COVID-19 Manuscript Submissions

Read the letter from AASLD journal Editors-in-Chief David Cohen, Paul Martin and Gyongyi Szabo.

COVID-19 Discussion Community in Engage

AASLD members have an outlet to share and discuss COVID-19 and how it's affecting care delivery to patients with liver disease.

Join the conversation.

Write your Congressional Representatives and Senators

Join us and make your voice heard: Use our online advocacy tool to send an email to your legislators about how COVID-19 is impacting you and what needs to be done to protect you, your colleagues and your patients during this urgent time.

 

Journal References for COVID-19

AASLD Journal Articles

Resources from Other Publishers